The interest in exploring new tools for process analytical technology (PAT) in biopharmaceutical drug development and manufacturing is strong throughout the industry. However, despite the concept being well accepted and supported for almost two decades, the adoption of PAT in manufacturing settings is slower than first anticipated.
Login now to read the full article
Don’t have an account yet? Subscribe now, it’s free!
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt.
All pubblications
archive from 2022 to today
All articles
PDF Version
Receive our latest issue alerts
directly to your mailbox